Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.

LR, Feldstein; MW, Tenforde; KG, Friedman; M, Newhams; EB, Rose; H, Dapul; VL, Soma; AB, Maddux; PM, Mourani; C, Bowens; M, Maamari; MW, Hall; BJ, Riggs; JS Jr, Giuliano; AR, Singh; S, Li; M, Kong; JE, Schuster; GE, McLaughlin; SP, Schwartz; TC, Walker; LL, Loftis; CV, Hobbs; NB, Halasa; S, Doymaz; CJ, Babbitt; JR, Hume; SJ, Gertz; K, Irby; KN, Clouser; NZ, Cvijanovich; TT, Bradford; LS, Smith; SM, Heidemann; SP, Zackai; K, Wellnitz; RA, Nofziger; SM, Horwitz; RW, Carroll; CM, Rowan; KM, Tarquinio; EH, Mack; JC, Fitzgerald; BM, Coates; AM, Jackson; CC, Young; MBF, Son; MM, Patel; JW, Newburger; AG, Randolph

doi:10.1001/jama.2021.2091

Public

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.

Shared by NobleBlocks on Mar 1, 2021 • 12:00 AM UTC

Authors:

Feldstein LR

Tenforde MW

Friedman KG

Abstract

Importance Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C) may inform efforts to improve health outcomes.Objective To compare clinical characteristics and outcomes of children and adolescents with MIS-C vs those with severe coronavirus disease 2019 (COVID-19).Setting...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!